These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10673673)

  • 1. Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients.
    Vescio RA; Wu CH; Zheng L; Sheen D; Ma H; Liu J; Stewart AK; Ballester O; Noga SJ; Rugo H; Freytes C; Stadtmauer E; Sahebi F; Tarantolo S; Stiff P; Schiller GJ; White M; Jacobs C; DiPersio J; Anderson KC; Berenson JR
    Bone Marrow Transplant; 2000 Jan; 25(2):153-60. PubMed ID: 10673673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of human herpesvirus 8 in stem cell collections from myeloma patients.
    Cull GM; Carter GI; Timms JM; Thomson BJ; Russell NH; Haynes AP
    Bone Marrow Transplant; 1999 Apr; 23(8):759-61. PubMed ID: 10231136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HHV-8 and multiple myeloma.
    Berenson JR; Vescio RA
    Pathol Biol (Paris); 1999 Feb; 47(2):115-8. PubMed ID: 10192878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) DNA sequences are absent in leukapheresis products and ex vivo expanded CD34+ cells from multiple myeloma patients.
    De Greef C; Van De Voorde W; Bakkus M; Corthals J; Heirman C; Schots R; Lacor P; Van Camp B; Van Riet I
    Br J Haematol; 1999 Sep; 106(4):1033-6. PubMed ID: 10520008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield.
    Kiel K; Cremer FW; Ehrbrecht E; Wallmeier M; Hegenbart U; Goldschmidt H; Moos M
    Bone Marrow Transplant; 1998 Jun; 21(11):1109-15. PubMed ID: 9645573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    López-Pérez R; García-Sanz R; González D; Balanzategui A; Chillón MC; Alaejos I; Mateos MV; Caballero MD; Corral M; Orfão A; González M; San Miguel JF
    Bone Marrow Transplant; 2001 Oct; 28(7):665-72. PubMed ID: 11704789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
    Dyson PG; Horvath N; Joshua D; Barrow L; Van Holst NG; Brown R; Gibson J; To LB
    Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpesvirus-8 infection of umbilical cord-blood-derived CD34+ stem cells enhances the immunostimulatory function of their dendritic cell progeny.
    Larcher C; Nguyen VA; Fürhapter C; Ebner S; Sölder E; Stössel H; Romani N; Sepp N
    Exp Dermatol; 2005 Jan; 14(1):41-9. PubMed ID: 15660918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human herpesvirus 8 DNA sequences in peripheral blood mononuclear cells of children.
    Kikuta H; Itakura O; Ariga T; Kobayashi K
    J Med Virol; 1997 Sep; 53(1):81-4. PubMed ID: 9298737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature.
    Jacoub JF; Suryadevara U; Pereyra V; Colón D; Fontelonga A; Mackintosh FR; Hall SW; Ascensão JL
    Exp Hematol; 2006 Nov; 34(11):1443-50. PubMed ID: 17046563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukapheresis cells of patients with multiple myeloma collected after mobilization with chemotherapy and G-CSF do not bear Kaposi's sarcoma associated herpesvirus DNA.
    Bellos F; Cremer FW; Ehrbrecht E; Goldschmidt H; Moos M
    Br J Haematol; 1998 Dec; 103(4):1192-7. PubMed ID: 9886341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of high yield and purify of CD34(+) cell-selected PBPC, collected from patients with multiple myeloma.
    Webb IJ; Scholssman RL; Jiroutek M; Doss D; Cohen CA; Freeman A; Schott DM; Anderson KC
    Cytotherapy; 1999; 1(3):175-82. PubMed ID: 12881173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpesvirus 6A DNA Is detected frequently in plasma but rarely in peripheral blood leukocytes of patients after bone marrow transplantation.
    Nitsche A; Müller CW; Radonic A; Landt O; Ellerbrok H; Pauli G; Siegert W
    J Infect Dis; 2001 Jan; 183(1):130-3. PubMed ID: 11076708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of HHV-8 infection in HIV-positive patients with and without Kaposi sarcoma: diagnostic relevance of serology and PCR.
    Albrecht D; Meyer T; Lorenzen T; Stoehr A; Arndt R; Plettenberg A
    J Clin Virol; 2004 Jun; 30(2):145-9. PubMed ID: 15125870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local irradiation prior to stem cell harvest has no influence on CD34+ yield: a quantitative analysis.
    Rinn JP; Schwella N; Wollmer E; Jaques G; Heinzel-Gutenbrunner M; Strassmann G; Gross MW; Movassaghi K; Neubauer A; Ritter M
    Ann Hematol; 2006 Jan; 85(1):38-44. PubMed ID: 16012838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
    Bruns I; Steidl U; Kronenwett R; Fenk R; Graef T; Rohr UP; Neumann F; Fischer J; Scheid C; Hübel K; Haas R; Kobbe G
    Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow failure associated with human herpesvirus 8 infection after transplantation.
    Luppi M; Barozzi P; Schulz TF; Setti G; Staskus K; Trovato R; Narni F; Donelli A; Maiorana A; Marasca R; Sandrini S; Torelli G
    N Engl J Med; 2000 Nov; 343(19):1378-85. PubMed ID: 11070102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity.
    Gojo I; Guo C; Sarkodee-Adoo C; Meisenberg B; Fassas A; Rapoport AP; Cottler-Fox M; Heyman M; Takebe N; Tricot G
    Bone Marrow Transplant; 2004 Jul; 34(1):69-76. PubMed ID: 15133484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients.
    Ljungman P; Wang FZ; Clark DA; Emery VC; Remberger M; Ringdén O; Linde A
    Br J Haematol; 2000 Dec; 111(3):774-81. PubMed ID: 11122137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.